NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT05565417 2025-10-16Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasImmunitas TherapeuticsPhase 1/2 Active not recruiting67 enrolled